Long-term use of proton-pump inhibitors: whole-of-population patternsin Australia 2013–2016

摘要

Proton-pump inhibitors (PPIs) are among the most prescribed medicinesworldwide and concern about their long-term use is growing. We useddispensing claims for every person in Australia dispensed publiclysubsidized PPIs between 2013 and 2016 to determine the incidence andprevalence of PPI use and to examine the patterns and durations of PPItreatment among individuals continuing treatment beyond theguideline-recommended maximum 12 weeks.